Actively Recruiting
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Led by University of Zurich · Updated on 2024-04-11
100
Participants Needed
1
Research Sites
35 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial evaluates ultra low dose computed tomography (CT) scan protocols and the use of Iomeron 400 contrast in photon-counting detector CT (PCD-CT) imaging. It focuses on participants needing CT scans for lung conditions such as pulmonary nodules, pneumonia, lung embolism, or lung cancer. The study aims to compare radiation dose reduction while maintaining image quality in these scans. Participants will undergo either a standard low dose CT scan or an ultra low dose CT scan using the new PCD-CT technology with Iomeron 400 contrast. The study is non-randomized and open-label, meaning participants know which scan protocol they receive. The primary focus is on dose reduction and image quality over about one year of follow-up. During the study, participants will have chest CT scans to detect or monitor lung issues. Researchers will assess radiation dose reduction achieved by the new scanner and monitor image quality stability during reduced dose scans. The total study duration is approximately one year, and safety and scan effectiveness are tracked throughout this period.
CONDITIONS
Brief Title
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- CT scan for pulmonary nodule detection or follow-up
- CT scan for pneumonia detection or follow-up
- Age 18 years or older
You will not qualify if you...
- Under 18 years of age
- Body mass index (BMI) over 30
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants undergo computed tomography scans using either standard low dose or ultra low dose settings to evaluate pulmonary conditions.
1 or more visits depending on clinical need
Trial Site Locations
Total: 1 location
1
University Hospital Zurich - Diagnostic Radiology
Zurich, Switzerland, 8091
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here